Concepedia

Daoping Zhou

DZ

Statistics

Publications

14

Citations

971

H-Index

14

Active since

1995

Affiliations

Nanjing Medical University(Current)

Wuxi People's Hospital

University of Massachusetts Boston

Anhui Provincial Hospital

Jiangnan University

Daoping Zhou is an author at Nanjing Medical University specializing in breast cancer, radiation oncology, and cell biology.

ORCID

Top concepts

Publications per year

1995–2022

14

Publications

14

RETRACTED: Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer

Juan Gu, Yueping Wang, Xuedong Wang et al. · Cancer Letters · 2018 · 143 citations

, , +9

Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway

Guang Shan, Juan Gu, Daoping Zhou et al. · Experimental & Molecular Medicine · 2020 · 118 citations · Full text

Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN

Guang Shan, Xike Zhou, Juan Gu et al. · Cellular Oncology · 2021 · 111 citations · Full text

Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia.

Daoping Zhou, R Zittoun, J. P. Marie · PubMed · 1995 · 111 citations

Homoharringtonine: an effective new natural product in cancer chemotherapy.

Daoping Zhou, R Zittoun, J. P. Marie · PubMed · 1995 · 97 citations

1–5 of 14